GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression

GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investi...

Full description

Bibliographic Details
Main Authors: Seung-Jin Lee, Dong-Soon Im
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/13084
_version_ 1797507701195931648
author Seung-Jin Lee
Dong-Soon Im
author_facet Seung-Jin Lee
Dong-Soon Im
author_sort Seung-Jin Lee
collection DOAJ
description GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investigated in human THP-1 monocytes and ApoE<sup>−/−</sup> mice using O-1602 (a potent agonist of GPR55) and CID16020046 (a specific GPR55 antagonist). O-1602 treatment significantly increased monocyte adhesion to human umbilical vein endothelial cells, and the O-1602-induced adhesion was inhibited by treatment with CID16020046. O-1602 induced the expression of Mac-1 adhesion molecules, whereas CID16020046 inhibited this induction. Analysis of the promoter region of <i>Mac-1</i> elucidated the binding sites of AP-1 and NF-κB between nucleotides −750 and −503 as GPR55 responsive elements. O-1602 induction of Mac-1 was found to be dependent on the signaling components of GPR55, that is, Gq protein, Ca<sup>2+</sup>, CaMKK, and PI3K. In Apo<sup>−/</sup><sup>−</sup> mice, administration of CID16020046 ameliorated high-fat diet-induced atherosclerosis development. These results suggest that high-fat diet-induced GPR55 activation leads to the adhesion of monocytes to endothelial cells via induction of Mac-1, and CID16020046 blockage of GPR55 could suppress monocyte adhesion to vascular endothelial cells through suppression of Mac-1 expression, leading to protection against the development of atherosclerosis.
first_indexed 2024-03-10T04:52:10Z
format Article
id doaj.art-4bd20e0282a94b1e95105b69aa866ce2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:52:10Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4bd20e0282a94b1e95105b69aa866ce22023-11-23T02:32:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122231308410.3390/ijms222313084GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 ExpressionSeung-Jin Lee0Dong-Soon Im1Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, KoreaEast West Pharmaceutical Research Center, Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, KoreaGPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investigated in human THP-1 monocytes and ApoE<sup>−/−</sup> mice using O-1602 (a potent agonist of GPR55) and CID16020046 (a specific GPR55 antagonist). O-1602 treatment significantly increased monocyte adhesion to human umbilical vein endothelial cells, and the O-1602-induced adhesion was inhibited by treatment with CID16020046. O-1602 induced the expression of Mac-1 adhesion molecules, whereas CID16020046 inhibited this induction. Analysis of the promoter region of <i>Mac-1</i> elucidated the binding sites of AP-1 and NF-κB between nucleotides −750 and −503 as GPR55 responsive elements. O-1602 induction of Mac-1 was found to be dependent on the signaling components of GPR55, that is, Gq protein, Ca<sup>2+</sup>, CaMKK, and PI3K. In Apo<sup>−/</sup><sup>−</sup> mice, administration of CID16020046 ameliorated high-fat diet-induced atherosclerosis development. These results suggest that high-fat diet-induced GPR55 activation leads to the adhesion of monocytes to endothelial cells via induction of Mac-1, and CID16020046 blockage of GPR55 could suppress monocyte adhesion to vascular endothelial cells through suppression of Mac-1 expression, leading to protection against the development of atherosclerosis.https://www.mdpi.com/1422-0067/22/23/13084GPR55CID16020046atherosclerosismonocyte adhesionMac-1
spellingShingle Seung-Jin Lee
Dong-Soon Im
GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
International Journal of Molecular Sciences
GPR55
CID16020046
atherosclerosis
monocyte adhesion
Mac-1
title GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
title_full GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
title_fullStr GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
title_full_unstemmed GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
title_short GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
title_sort gpr55 antagonist cid16020046 protects against atherosclerosis development in mice by inhibiting monocyte adhesion and mac 1 expression
topic GPR55
CID16020046
atherosclerosis
monocyte adhesion
Mac-1
url https://www.mdpi.com/1422-0067/22/23/13084
work_keys_str_mv AT seungjinlee gpr55antagonistcid16020046protectsagainstatherosclerosisdevelopmentinmicebyinhibitingmonocyteadhesionandmac1expression
AT dongsoonim gpr55antagonistcid16020046protectsagainstatherosclerosisdevelopmentinmicebyinhibitingmonocyteadhesionandmac1expression